Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Current Oncology (Toronto, Ont.)|March 29, 2020
Prognosis in young women less than 40 years of age with brain metastasis from breast cancerA Mustillo, J P Ayoub, D Charpentier, et al.
Leukemia & Lymphoma|September 24, 1999
Therapeutic and prognostic implications of peripheral blood lymphopenia in patients with Hodgkin's diseaseJ P Ayoub, J L Palmer, Y Huh, et al.
American Journal of Otolaryngology|December 15, 2000
Synchronous appearance of germ cell tumor and papillary carcinoma of the thyroidJ P Ayoub, R J Amato, A Chiu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Unknown primary tumors metastatic to liverJ P Ayoub, K R Hess, M C Abbruzzese, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 28, 2001
Pharmacologic insights into the future of trastuzumabB Leyland-Jones, A Arnold, K Gelmon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1996
No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion scheduleA Younes, J P Ayoub, F B Hagemeister, et al.
Current Oncology (Toronto, Ont.)|February 17, 2015
Novel agents and associated toxicities of inhibitors of the pi3k/Akt/mtor pathway for the treatment of breast cancerS Chia, S Gandhi, A A Joy, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1997
Paclitaxel (Taxol) for the treatment of lymphomaA Younes, J P Ayoub, A Sarris, et al.
British Journal of Haematology|February 1, 1997
Paclitaxel activity for the treatment of non-Hodgkin's lymphoma: final report of a phase II trialA Younes, J P Ayoub, A Sarris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Veliparib monotherapy following carboplatin/paclitaxel plus veliparib combination therapy in patients with germline BRCA-associated advanced breast cancer: results of exploratory analyses from the phase III BROCADE3 trialH S Han, B K Arun, B Kaufman, et al.
Pageof 1